On August 4, 2023, Dr. Matthew Angel resigned from the Board and as Eterna Therapeutics Inc.?s President. At a meeting of the Board on August 9, 2023, the Board reappointed Dr. Angel as the Company?s President on the same terms on which Dr. Angel served immediately prior to his resignation. On August 8, 2023, Mr. Brant C. Binder and Dr. Richard W. Wagner resigned from the Board, including from the audit and compensation committees thereof, of which they were two of three members, as well as from the Transaction Committee referenced in the Angel Letter.

The Board is currently composed of Mr. William Wexler and Dr. Gregory Fiore.